Literature DB >> 15715025

Postnatal blues: a risk factor for postnatal depression.

C Henshaw1, D Foreman, J Cox.   

Abstract

Postnatal blues have been regarded as brief, benign and without clinical significance. However, several studies have proposed a link between blues and subsequent depression but have methodological problems. We report a prospective, controlled study of postpartum women with severe blues which uses systematically devised and validated instruments for that purpose which tests the hypothesis that severe blues increases the risk of depression in the six months following childbirth. 206 first-time mothers were recruited in late pregnancy. Blues status was defined using the Blues Questionnaire and those with severe blues and their controls who had no blues (matched for age, marital status and social class) were followed for 6 months with postal Edinburgh Postnatal Depression Scale. RDC diagnoses were made following SADS-L interview at the end of the protocol. Backwards stepwise Cox regression analysis found severe blues and past history of depression to be independent predictors each raising the risk by almost 3 times. Depression in those with severe blues onset sooner after delivery and lasted longer. The difference was largely accounted for by major depression. Severe postpartum blues are identified as an independent risk factor for subsequent postpartum depression. Screening and intervention programs could be devised.

Entities:  

Mesh:

Year:  2004        PMID: 15715025     DOI: 10.1080/01674820400024414

Source DB:  PubMed          Journal:  J Psychosom Obstet Gynaecol        ISSN: 0167-482X            Impact factor:   2.949


  13 in total

1.  Subjective perception of sleep, but not its objective quality, is associated with immediate postpartum mood disturbances in healthy women.

Authors:  Bei Bei; Jeannette Milgrom; Jennifer Ericksen; John Trinder
Journal:  Sleep       Date:  2010-04       Impact factor: 5.849

Review 2.  Common and divergent psychobiological mechanisms underlying maternal behaviors in non-human and human mammals.

Authors:  Joseph S Lonstein; Frédéric Lévy; Alison S Fleming
Journal:  Horm Behav       Date:  2015-06-27       Impact factor: 3.587

3.  Screening for Postnatal Depression in a Tertiary Care Hospital.

Authors:  C N Sheela; Shilpa Venkatesh
Journal:  J Obstet Gynaecol India       Date:  2015-10-10

Review 4.  Perinatal depression: treatment options and dilemmas.

Authors:  Teri Pearlstein
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

5.  Sleep quality in women with and without postpartum depression.

Authors:  Bobbie Posmontier
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2008 Nov-Dec

Review 6.  Emotion and mood adaptations in the peripartum female:complementary contributions of GABA and oxytocin.

Authors:  J S Lonstein; J Maguire; G Meinlschmidt; I D Neumann
Journal:  J Neuroendocrinol       Date:  2014-10       Impact factor: 3.627

7.  Postpartum changes in affect-related behavior and VTA dopamine neuron activity in rats.

Authors:  Millie Rincón-Cortés; Anthony A Grace
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-10-23       Impact factor: 5.067

8.  Factors associated with early postpartum maternity blues and depression tendency among Japanese mothers with full-term healthy infants.

Authors:  Yuki Takahashi; Koji Tamakoshi
Journal:  Nagoya J Med Sci       Date:  2014-02       Impact factor: 1.131

9.  Exposure to active and passive smoking among Greek pregnant women.

Authors:  Victoria G Vivilaki; Athina Diamanti; Maria Tzeli; Evridiki Patelarou; Debra Bick; Sophia Papadakis; Katerina Lykeridou; Paraskevi Katsaounou
Journal:  Tob Induc Dis       Date:  2016-04-05       Impact factor: 2.600

10.  Examining early structural and functional brain alterations in postpartum depression through multimodal neuroimaging.

Authors:  Natalia Chechko; Juergen Dukart; Patricia Schnakenberg; Lisa Hahn; Susanne Stickel; Elmar Stickeler; Ute Habel; Simon B Eickhoff
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.